STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. Its products include XTRAC and Pharos excimer lasers, VTRAC lamp systems, and TheraClear treatment systems that are used for the treatment of psoriasis, vitiligo, acne, and other …
Over the last 12 months, insiders at STRATA Skin Sciences, Inc. have bought $1.52M and sold $320 worth of STRATA Skin Sciences, Inc. stock.
On average, over the past 5 years, insiders at STRATA Skin Sciences, Inc. have bought $565,361 and sold $320 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Accelmed Partners, L.P. (10 percent owner) — $723,999. Geiger Uri () — $723,999. Rafaeli Dolev (Chief Executive Officer) — $59,974.
The last purchase of 230,573 shares for transaction amount of $723,999 was made by Geiger Uri () on 2024‑07‑15.
2024-07-15 | 230,573 6.5974% | $3.14 | $723,999 | 0.00% | ||||
2024-07-15 | 10 percent owner | 230,573 6.5974% | $3.14 | $723,999 | 0.00% | |||
2024-07-15 | Chief Executive Officer | 19,100 0.5465% | $3.14 | $59,974 | 0.00% | |||
2023-12-01 | COO | 20,000 0.0586% | $0.45 | $8,956 | -5.01% | |||
2023-11-16 | Sale | director | 1,000 0.0021% | $0.32 | $320 | -2.87% | ||
2023-08-16 | 10 percent owner | 1.85M 5.0569% | $0.55 | $1.02M | -11.47% | |||
2023-08-10 | Chief Executive Officer | 42,000 0.1268% | $0.67 | $28,308 | -18.75% | |||
2023-08-10 | Chief Financial Officer | 15,151 0.0455% | $0.67 | $10,153 | -18.75% | |||
2022-06-15 | 1,050 0.0031% | $1.04 | $1,092 | -2.97% | ||||
2022-05-12 | Chief Financial Officer | 23,131 0.0691% | $1.12 | $25,907 | -7.96% | |||
2022-03-25 | 16,950 0.0523% | $1.73 | $29,385 | -38.40% | ||||
2022-03-24 | Chief Executive Officer | 33,300 0.0962% | $1.57 | $52,398 | -36.37% | |||
2022-03-24 | 14,783 0.043% | $1.58 | $23,387 | -36.37% | ||||
2021-09-08 | director | 44,808 0.1677% | $1.47 | $65,951 | -5.96% | |||
2021-09-07 | director | 26,612 0.0995% | $1.42 | $37,726 | -2.41% | |||
2019-11-21 | director | 5,000 0.0158% | $2.50 | $12,500 | -44.13% | |||
2018-06-14 | CFO | 10,000 0.0431% | $1.96 | $19,618 | +42.05% | |||
2018-06-14 | director | 5,000 0.0214% | $1.95 | $9,750 | +42.05% | |||
2018-06-08 | director | 30,000 0.1314% | $2.12 | $63,500 | +34.06% | |||
2018-06-05 | director | 20,000 0.0855% | $2.01 | $40,122 | +37.81% |
Geiger Uri | 1441835 34.5668% | $3.15 | 1 | 0 | ||
Accelmed Partners, L.P. | 10 percent owner | 1441835 34.5668% | $3.15 | 1 | 0 | |
Rubinstein Samuel | director | 177602 4.2579% | $3.15 | 1 | 1 | |
Rafaeli Dolev | Chief Executive Officer | 143156 3.432% | $3.15 | 1 | 0 | |
Gov Shmuel | COO | 20000 0.4795% | $3.15 | 1 | 0 |
22Nw Fund Lp | $2.03B | 153.16 | 5.37M | 0% | +$0 | 95.37 | |
Nantahala Capital Management Llc | $1.17B | 88.13 | 3.09M | -1.23% | -$14.48M | 54.38 | |
Renaissance Technologies | $402,000.00 | 30.31 | 1.06M | -0.43% | -$1,739.85 | <0.01 | |
The Vanguard Group | $324.4M | 24.48 | 858,202 | 0% | +$0 | 0.01 | |
One Seven (We Are One Seven, LLC) | $64.8M | 4.89 | 171,420 | +140.02% | +$37.8M | 3.47 |